EUVIMEDEUVIMED entdecken
Open Access

Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications

Mirjana Macvanin, Dušan Spasić, Sanja Gluscevic, Tatjana Srdić-Rajić, Aleksandra Klisic

Archives of Medical Science · 20.08.2026

DOI: 10.5114/aoms/225096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Medical Science, online erschienen am 20.08.2026. Verfasst von Mirjana Macvanin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Technology and Metallurgy, Center for Chemistry, National Institute of the Republic of Serbia, University of Belgrade, Serbia. Die Arbeit nennt 223 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a programmed cell death characterized by excessive, iron-dependent accumulation of membrane lipid peroxides due to insufficient glutathione-dependent antioxidant defense. It is influenced by the metabolism of amino acids, lipids, and iron, and occurs in conditions of decreased glutathione peroxidase 4 (GPX4) activity. The increased polyunsaturated fatty acid (PUFA) content in membrane phospholipids is associated with cellular hypersusceptibility to ferroptosis. In contrast, incorporation of monounsaturated fatty acids may protect cells against ferroptotic cell death. Cellular sensitivity to ferroptosis is additionally influenced by glutamine catabolism and the xc–system-mediated import of cystine, which modulate glutathione production, and by elevated iron levels, which lead to the buildup of reactive oxygen species (ROS) that attack membrane-localized PUFAs. This review focuses on recent findings of perturbed metabolic processes in cancer that create a high iron demand and an altered lipid composition, thereby predisposing cells to ferroptosis. We analyze the therapeutic potential of pharmacological agents that can selectively trigger ferroptosis in tumor cells.

Schlagwörter

Stichwörter der Autor:innen

GPX4cancer therapeuticsferroptosisglutathione metabolismiron metabolismlipid metabolismredox homeostasis

Autor:innen und Institutionen

  • Institute of Chemistry, Technology and Metallurgy, Center for Chemistry, National Institute of the Republic of Serbia, University of Belgrade, Serbia.
  • University of Belgrade ‒ Faculty of Medicine, Department of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia.
  • Clinical Center of Montenegro, Department of Neurology, Podgorica, Montenegro.
  • Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia.
  • University of Montenegro, Faculty of Medicine, Podgorica, Montenegro.
  • Center for Laboratory Diagnostics, Primary Health Care Center, Podgorica, Montenegro.

Zitieren

APA

Macvanin, M., Spasić, D., Gluscevic, S., Srdić-Rajić, T., & Klisic, A. (2026). Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications. Archives of Medical Science. https://doi.org/10.5114/aoms/225096

Vancouver

Macvanin M, Spasić D, Gluscevic S, Srdić-Rajić T, Klisic A. Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications. Archives of Medical Science. 2026. doi:10.5114/aoms/225096

BibTeX
@article{Macvanin2026,
  author = {Macvanin, Mirjana and Spasić, Dušan and Gluscevic, Sanja and Srdić-Rajić, Tatjana and Klisic, Aleksandra},
  title = {Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications},
  journal = {Archives of Medical Science},
  year = {2026},
  doi = {10.5114/aoms/225096}
}
Kostenlos starten →